For help on how to get the results you want, see our search tips.
582 results
Categories
Human Remove Human filter
Medicine
Summaries of opinion Remove Summaries of opinion filter
Orphan designations Remove Orphan designations filter
Orphan designation status
Withdrawn Remove Withdrawn filter
-
List item
Orphan designation: Sodium phenylbutyrate for: Treatment of ornithine-transcarbamylase deficiency
Date of first decision: 09/02/2012, Withdrawn, -
List item
Orphan designation: Acetylcysteine for: Treatment of idiopathic pulmonary fibrosis
Date of first decision: 26/01/2005, Withdrawn, -
List item
Orphan designation: Plitidepsin for: Treatment of post-essential thrombocythaemia myelofibrosis
Date of first decision: 23/02/2011, Withdrawn, -
List item
Orphan designation: Olaratumab for: Treatment of soft tissue sarcoma
Date of first decision: 12/02/2015, Withdrawn, Last updated: 15/01/2020 -
List item
Orphan designation: 2'-deoxyguanosylyl-(3',5'-phosphoryl)-2'-deoxythymidylyl-(3',5'-phosphoryl)- 2'-deoxyguanosylyl-(3',5'-phosphoryl)-2'-deoxycytidylyl-(3',5'-phosphoryl)-2'-deoxycytidylyl -(3',5'-phosphoryl)-2'-deoxycytidylyl-(3',5'-phosphoryl)-2'-deoxyguanosylyl... for: Treatment of diffuse large B-cell lymphoma
Date of first decision: 10/08/2015, Withdrawn, -
List item
Orphan designation: Suberolylanilide hydroxamic acid for: Treatment of cutaneous T-cell lymphoma
Date of first decision: 21/06/2004, Withdrawn, Last updated: 12/03/2013 -
List item
Orphan designation: [N-((2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S,Z)-3,6,11',12b'-tetramethyl-2',3a,3',4,4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,3H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-3'-yl)methanesulfonamide hydrochloride] for: Treatment of chondrosarcoma
Date of first decision: 13/05/2011, Withdrawn, -
List item
Orphan designation: Idelalisib for: Treatment of splenic marginal-zone lymphoma
Date of first decision: 05/08/2013, Withdrawn, -
List item
Orphan designation: Trientine tetrahydrochloride for: Treatment of Wilson's disease
Date of first decision: 19/03/2015, Withdrawn, -
List item
Orphan designation: Thalidomide for: Treatment of graft-versus-host disease
Date of first decision: 09/07/2001, Withdrawn, Last updated: 15/10/2009 -
List item
Orphan designation: ciclosporin for: Prevention of rejection for corneal transplant
Date of first decision: 03/11/2006, Withdrawn, Last updated: 15/03/2010 -
List item
Orphan designation: (Z)-N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysyccinate for: Treatment of malignant gastrointestinal stromal tumours
Date of first decision: 10/03/2005, Withdrawn, Last updated: 15/10/2009 -
List item
Orphan designation: Tralokinumab for: Treatment of idiopathic pulmonary fibrosis
Date of first decision: 08/11/2012, Withdrawn, -
List item
Orphan designation: Recombinant human serum amyloid P for: Prevention of scarring post glaucoma filtration surgery
Date of first decision: 09/10/2009, Withdrawn, -
List item
Orphan designation: Vatreptacog alfa (activated) for: Treatment of haemophilia B
Date of first decision: 09/08/2012, Withdrawn, -
List item
Orphan designation: milciclib maleate for: Treatment of malignant thymoma (updated)
Date of first decision: 08/11/2012, Withdrawn, Last updated: 22/03/2021 -
List item
Orphan designation: Ethanol for: Treatment of congenital venous malformations
Date of first decision: 09/03/2004, Withdrawn, Last updated: 18/01/2016 -
List item
Orphan designation: Diphenylcyclopropenone for: Treatment of alopecia totalis
Date of first decision: 29/06/2006, Withdrawn, Last updated: 19/09/2013 -
List item
Orphan designation: Recombinant human C1-inhibitor for: Treatment of angioedema caused by C1 inhibitor deficiency
Date of first decision: 11/05/2001, Withdrawn, Last updated: 18/11/2010 -
List item
Orphan designation: Pegylated recombinant factor VIIa for: Treatment of haemophilia B
Date of first decision: 03/06/2008, Withdrawn, -
List item
Orphan designation: Purified inactivated Japanese encephalitis SA14-4-2 virus vaccine for: Prevention of Japanese encephalitis
Date of first decision: 24/01/2006, Withdrawn, -
List item
Orphan designation: unoprostone isopropyl for: Treatment of retinitis pigmentosa
Date of first decision: 19/06/2013, Withdrawn, -
List item
Orphan designation: Nilotinib hydrochloride monohydrate for: Treatment of gastrointestinal stromal tumours
Date of first decision: 13/04/2007, Withdrawn, -
List item
Orphan designation: Recombinant antibody derivative against human CD19 and CD3 (blinatumomab) for: Treatment of chronic lymphocytic leukaemia
Date of first decision: 01/12/2003, Withdrawn, Last updated: 11/12/2020 -
List item
Orphan designation: Allogeneic ex-vivo-expanded umbilical-cord blood cells for: Treatment of acute myeloid leukaemia
Date of first decision: 27/02/2009, Withdrawn,